HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiromichi Ito Selected Research

Sinistral Portal Hypertension

10/2021Sinistral Portal Hypertension after Pancreaticoduodenectomy with Splenic Vein Resection: Pathogenesis and Its Prevention.
1/2021Sinistral Portal Hypertension Prediction During Pancreatoduodenectomy With Splenic Vein Resection.
10/2019Techniques for splenic vein reconstruction after pancreaticoduodenectomy with portal vein resection for pancreatic cancer.
1/2019Impact of portal vein resection with splenic vein reconstruction after pancreatoduodenectomy on sinistral portal hypertension: Who needs reconstruction?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiromichi Ito Research Topics

Disease

51Neoplasms (Cancer)
08/2022 - 09/2003
31Pancreatic Neoplasms (Pancreatic Cancer)
08/2022 - 08/2003
20Neoplasm Metastasis (Metastasis)
06/2022 - 02/2004
20Adenocarcinoma
01/2022 - 09/2003
4Sinistral Portal Hypertension
10/2021 - 01/2019
3Brain Diseases (Brain Disorder)
11/2019 - 07/2004
3Seizures (Absence Seizure)
11/2019 - 10/2004
3Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 02/2012
3Autism Spectrum Disorder
01/2017 - 02/2013
3Pancreatitis
12/2008 - 09/2005
2Diarrhea
01/2022 - 01/2019
2Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021 - 08/2006
2Colic (Abdominal Cramps)
01/2019 - 01/2017
2Pulmonary Emphysema
03/2013 - 03/2013
2Pathologic Constriction (Stenosis)
05/2012 - 01/2011
2Carcinoma (Carcinomatosis)
03/2011 - 10/2009
2Chronic Pancreatitis
01/2011 - 10/2010
2Epilepsy (Aura)
10/2005 - 10/2004
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
05/2022
1Hemangiosarcoma (Angiosarcoma)
04/2022
1Stomach Neoplasms (Stomach Cancer)
02/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
02/2022
1Portal Hypertension
10/2021
1Hemangioma (Angioma)
06/2021
1Liposarcoma
06/2021
1Colonic Neoplasms (Colon Cancer)
01/2021
1Hemorrhage
01/2021
1Rectal Neoplasms (Rectal Cancer)
01/2021
1Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2020
1Infantile Spasms (West Syndrome)
11/2019
1Patent Ductus Arteriosus
11/2019
1Disease Progression
06/2019
1Rupture
01/2019
1Varicose Veins (Varicose Vein)
01/2019
1Fistula
12/2018
1Pancreatic Fistula (Pancreatic Fistulas)
10/2018
1Due To Mecp2 Mutations Neonatal Severe Encephalopathy
01/2018

Drug/Important Bio-Agent (IBA)

14GemcitabineFDA Link
08/2022 - 11/2003
7Small Interfering RNA (siRNA)IBA
08/2016 - 02/2004
5Protons (Proton)IBA
01/2017 - 07/2008
5Messenger RNA (mRNA)IBA
01/2016 - 10/2009
5Cell Adhesion MoleculesIBA
10/2004 - 01/2004
5Carcinoembryonic AntigenIBA
10/2004 - 01/2004
4130-nm albumin-bound paclitaxelIBA
08/2022 - 02/2021
4Immunoglobulins (Immunoglobulin)IBA
07/2004 - 08/2003
3folfirinoxIBA
08/2022 - 04/2021
3Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
08/2015 - 05/2012
3Phosphotransferases (Kinase)IBA
08/2015 - 12/2003
3SteroidsIBA
05/2013 - 10/2005
2Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2012
2AntidiarrhealsIBA
01/2022 - 01/2019
2Opioid Analgesics (Opioids)IBA
01/2022 - 01/2019
2Proteins (Proteins, Gene)FDA Link
12/2021 - 05/2004
2Histones (Histone)IBA
12/2021 - 08/2016
2Pharmaceutical PreparationsIBA
01/2021 - 05/2013
2Indicators and Reagents (Reagents)IBA
01/2021 - 02/2020
2Zonisamide (Zonegran)FDA LinkGeneric
11/2019 - 07/2007
2Valproic Acid (Depakote)FDA LinkGeneric
11/2019 - 08/2006
2DNA (Deoxyribonucleic Acid)IBA
08/2016 - 08/2015
2RNA (Ribonucleic Acid)IBA
01/2013 - 02/2012
2N-acetylaspartate (N-acetyl aspartate)IBA
04/2011 - 07/2008
2GhrelinIBA
03/2008 - 09/2003
2AutoantibodiesIBA
10/2005 - 08/2003
2ProstaglandinsIBA
10/2004 - 05/2004
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
10/2004 - 05/2004
2Prostaglandins EIBA
10/2004 - 05/2004
2Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
08/2004 - 02/2004
2Peptides (Polypeptides)IBA
07/2004 - 09/2003
2Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
07/2004 - 05/2004
2Fibronectins (Fibronectin)IBA
05/2004 - 04/2004
2Focal Adhesion Protein-Tyrosine KinasesIBA
05/2004 - 11/2003
2src-Family KinasesIBA
04/2004 - 08/2003
1Paclitaxel (Taxol)FDA LinkGeneric
04/2022
1AlbuminsIBA
01/2022
1N-acetyltalosaminuronic acid (NAT)IBA
02/2021
1hydroxide ionIBA
01/2021
1Methylphenidate (Ritalin)FDA LinkGeneric
01/2021
1CarbohydratesIBA
02/2020
1AntigensIBA
02/2020
1Lamotrigine (Lamictal)FDA LinkGeneric
11/2019
1Phenobarbital (Luminal)FDA Link
11/2019
1WW Domain-Containing OxidoreductaseIBA
11/2019
1Factor XIII (Coagulation Factor XIII)IBA
12/2018

Therapy/Procedure

16Therapeutics
11/2021 - 11/2003
14Drug Therapy (Chemotherapy)
08/2022 - 12/2003
12Hepatectomy
06/2022 - 03/2010
10Pancreaticoduodenectomy
02/2022 - 10/2010
6Neoadjuvant Therapy
01/2022 - 12/2015
4Cholecystectomy
08/2011 - 04/2008
3Pancreatectomy
12/2021 - 01/2017
3Ligation
10/2019 - 08/2004
2Adjuvant Chemotherapy
05/2022 - 01/2019
2Stents
11/2021 - 05/2012
2Synchrotrons
09/2014 - 03/2013
2Length of Stay
12/2009 - 09/2005
1Laparotomy
06/2022
1Transjugular Intrahepatic Portasystemic Shunt
10/2021
1Laparoscopic Cholecystectomy
06/2021
1Tracheotomy
11/2019
1Surgical Splenorenal Shunt (Splenorenal Shunt)
01/2019